The higher dose especially was linked with less pain, fatigue, and joint soreness/stiffness (11, 12)
The investigators compared people who had used these drugs with clinically similar patients who had not received them, then assessed whether either group was more or less likely to develop substance use disorders
North Carolina sits in a similar position, with NPs operating under reduced practice authority requiring a supervisory arrangement with a physician
Lighter flow There isn't any evidence that semaglutide directly causes lighter periods
But transformative medications that cost $349 to $1,000+ per month, that insurers may or may not cover, that can be denied or discontinued at any time, create a painful gap between medical need and financial reality
By 2024, GLP-1 drugs had become blockbusters, with combined sales approaching $50 billion annually